138 related articles for article (PubMed ID: 23194136)
1. Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders.
Chang X; Wu J
Gynecol Endocrinol; 2013 Mar; 29(3):196-200. PubMed ID: 23194136
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
Pu D; Wu J; Liu J
Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
[TBL] [Abstract][Full Text] [Related]
3. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
Elassar A; Mann JS; Engmann L; Nulsen J; Benadiva C
Fertil Steril; 2011 Jan; 95(1):324-6. PubMed ID: 20797708
[TBL] [Abstract][Full Text] [Related]
4. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
Mohsen IA; El Din RE
Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study.
Madani T; Ashrafi M; Yeganeh LM
Gynecol Endocrinol; 2012 Feb; 28(2):102-5. PubMed ID: 22263965
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.
Chang EM; Han JE; Won HJ; Kim YS; Yoon TK; Lee WS
J Assist Reprod Genet; 2012 Mar; 29(3):225-30. PubMed ID: 22160464
[TBL] [Abstract][Full Text] [Related]
7. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates.
Hill MJ; McWilliams GD; Miller KA; Scott RT; Frattarelli JL
Fertil Steril; 2009 Mar; 91(3):739-43. PubMed ID: 18314123
[TBL] [Abstract][Full Text] [Related]
8. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
9. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
10. ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation.
Bercaire L; Nogueira SM; Lima PC; Alves VR; Donadio N; Dzik A; Cavagna M
JBRA Assist Reprod; 2018 Mar; 22(1):52-55. PubMed ID: 29303236
[TBL] [Abstract][Full Text] [Related]
11. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis.
Reynolds KA; Omurtag KR; Jimenez PT; Rhee JS; Tuuli MG; Jungheim ES
Hum Reprod; 2013 Nov; 28(11):2981-9. PubMed ID: 23887073
[TBL] [Abstract][Full Text] [Related]
12. A luteal estradiol protocol for expected poor-responders improves embryo number and quality.
Frattarelli JL; Hill MJ; McWilliams GDE; Miller KA; Bergh PA; Scott RT
Fertil Steril; 2008 May; 89(5):1118-1122. PubMed ID: 17658529
[TBL] [Abstract][Full Text] [Related]
13. Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response.
Li Y; Yang W; Chen X; Li L; Zhang Q; Yang D
Gynecol Endocrinol; 2016; 32(1):74-7. PubMed ID: 26370530
[TBL] [Abstract][Full Text] [Related]
14. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
15. The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis.
Gelbaya TA; Kyrgiou M; Tsoumpou I; Nardo LG
Fertil Steril; 2008 Dec; 90(6):2116-25. PubMed ID: 18178194
[TBL] [Abstract][Full Text] [Related]
16. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
17. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
[TBL] [Abstract][Full Text] [Related]
19. GnRHa to trigger final oocyte maturation: a time to reconsider.
Humaidan P; Papanikolaou EG; Tarlatzis BC
Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
[TBL] [Abstract][Full Text] [Related]
20. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
